AP01

· Avalyn Pharma Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AP01, covering 2026-04-06 to 2026-04-06. Get the full timeline:

Most recent: Clinical Trial Update: A Study Evaluating the Safety and Efficacy of Inhaled AP01 in Participants With Progressive Pulmonary Fibrosis [Phase 2]

See pricing